Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients

After initially hypothesizing a positive relationship between use of renin-angiotensin-aldosterone system inhibitors and risk of coronavirus disease 2019 (COVID-19), more recent evidence suggests negative associations. We examined whether COVID-19 risk differs according to antihypertensive drug clas...

詳細記述

保存先:
書誌詳細
出版年:Hypertension
主要な著者: Semenzato, Laura, Botton, Jérémie, Drouin, Jérôme, Baricault, Bérangère, Vabre, Clémentine, Cuenot, François, Penso, Laetitia, Herlemont, Philippe, Sbidian, Emilie, Weill, Alain, Dray-Spira, Rosemary, Zureik, Mahmoud
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2021
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7884243/
https://ncbi.nlm.nih.gov/pubmed/33423528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16314
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料